Clinical Research in Cardiology

, Volume 100, Issue 4, pp 373–377

Acquired long QT interval in a recurrent septic female patient with polymorphic ventricular tachycardia due to primary acute adrenal insufficiency

  • Roja Soutodeh
  • Jürgen Götz
  • Ulrich Tebbe
  • Alessandro Cuneo
Letter to the Editors

References

  1. 1.
    Bornstein S (2009) Predisposing factors for adrenal insufficiency. N Engl J Med 360:2328–2339PubMedCrossRefGoogle Scholar
  2. 2.
    Lovas K, Husebye E (2002) High prevalence and increasing incidence of Addison’s disease in western Norway. Clin Endocrinol (Oxf) 56:787–791CrossRefGoogle Scholar
  3. 3.
    Arlt W (2009) The approach to the adult with newly diagnosed adrenal insufficiency. J Clin Endocrinol Metab 94:1059–1067PubMedCrossRefGoogle Scholar
  4. 4.
    Bleicken B, Hahner S, Ventz M, Quinkler M (2010) Delayed diagnosis of adrenal insufficiency is common: a cross-sectional study in 216 patients. Am J Med Sci 339:525–531PubMedGoogle Scholar
  5. 5.
    Gotyo N, Kida M, Horiuchi T, Hirata Y (2009) Torsade de pointes associated with recurrent ampulla cardiomyopathy in a patient with idiopathic ACTH deficiency. Endocr J 56:807–815PubMedCrossRefGoogle Scholar
  6. 6.
    Izumi C, Inoko M, Kitaguchi S, Himura Y, Iga K, Gen H, Konishi T (1998) Polymorphic ventricular tachycardia in a patient with adrenal insufficiency and hypothyroidism. Jpn Circ J 62:543–545PubMedCrossRefGoogle Scholar
  7. 7.
    Nishizawa S, Nakamura T, Hamaoka T, Matsumuro A, Sawada T, Matsubara H (2009) Lethal arrhythmia and corticosteroid insufficiency. Am J Emerg Med 27:1167.e1–1167.e3Google Scholar
  8. 8.
    Somerville W (1950) The effect of cortisone on the cardiogram in chronic adrenal insufficiency. Br Med J 2:860–862PubMedCrossRefGoogle Scholar
  9. 9.
    Arlt W, Allolio B (2003) Adrenal insufficiency. Lancet 361:1881–1893PubMedCrossRefGoogle Scholar
  10. 10.
    Cushner G, Zahler S, Hills A (1963) Untreated Addison’s disease complicated by pulmonary congestion due to left ventricular failure. Ann Intern Med 58:341–346PubMedGoogle Scholar
  11. 11.
    Afzal A, Khaja F (2000) Reversible cardiomyopathy associated with Addison’s disease. Can J Cardiol 16:377–379PubMedGoogle Scholar
  12. 12.
    Fallo F, Betterle C, Budano S, Lupia M, Boscaro M, Sonino N (1999) Regression of cardiac abnormalities after replacement therapy in Addison’s disease. Eur J Endocrinol 140:425–428PubMedCrossRefGoogle Scholar
  13. 13.
    Somerville W, Levine H, Thorn G (1951) The electrocardiogram in Addison’s disease. Medicine (Baltimore) 30:43–79Google Scholar
  14. 14.
    Locati E, Maison-Blanche P, Dejode P, Cauchemez B, Coumel P (1995) Spontaneous sequences of onset of torsade de pointes in patients with acquired prolonged repolarization: quantitative analysis of Holter recordings. J Am Coll Cardiol 25:1564–1575PubMedCrossRefGoogle Scholar
  15. 15.
    Roden D (2004) Drug-induced prolongation of the QT interval. N Engl J Med 350:1013–1022PubMedCrossRefGoogle Scholar
  16. 16.
    Van Noord C, Eijgelsheim M, Stricker B (2010) Drug- and non-drug-associated QT interval prolongation. Br J Clin Pharmacol 70:16–23PubMedCrossRefGoogle Scholar
  17. 17.
    Hahner S, Loeffler M, Bleicken B, Drechsler C, Milovanovic D, Fassnacht M, Ventz M, Quinkler M, Allolio B (2010) Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies. Eur J Endocrinol 162:597–602PubMedCrossRefGoogle Scholar
  18. 18.
    Cooper MS, Stewart P (2003) Corticosteroid insufficiency in acutely ill patients. N Engl J Med 348:727–734PubMedCrossRefGoogle Scholar
  19. 19.
    Sprung C, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss Y, Benbenishty J, Kalenka A, Forst H, Laterre P, Reinhart K, Cuthbertson B, Payen D, Briegel J (2008) Hydrocortisone therapy for patients with septic shock. N Engl J Med 358:111–124PubMedCrossRefGoogle Scholar
  20. 20.
    Oelkers W, Diederich S, Bahr V (1992) Diagnosis and therapy surveillance in Addison’s disease: rapid adrenocorticotropin (ACTH) test and measurement of plasma ACTH, renin activity, and aldosterone. J Clin Endocrinol Metab 75:259–264PubMedCrossRefGoogle Scholar
  21. 21.
    Betterle C, Volpato M, Pedini B, Chen S, Smith B, Furmaniak J (1999) Adrenal-cortex autoantibodies and steroid-producing cells autoantibodies in patients with Addison’s disease: comparison of immunofluorescence and immunoprecipitation assays. J Clin Endocrinol Metab 84:618–622PubMedCrossRefGoogle Scholar
  22. 22.
    Lovas K, Loge J, Husebye ES (2002) Subjective health status in Norwegian patients with Addison’s disease. Clin Endocrinol (Oxf) 56:581–588CrossRefGoogle Scholar
  23. 23.
    Bleicken B, Hahner S, Loeffler M, Ventz M, Decker O, Allolio B, Quinkler M (2010) Influence of hydrocortisone dosage scheme on health-related quality of life in patients with adrenal insufficiency. Clin Endocrinol (Oxf) 72:297–304CrossRefGoogle Scholar
  24. 24.
    Bleicken B, Hahner S, Loeffler M, Ventz M, Allolio B, Quinkler M (2008) Impaired subjective health status in chronic adrenal insufficiency: impact of different glucocorticoid replacement regimens. Eur J Endocrinol 159:811–817PubMedCrossRefGoogle Scholar
  25. 25.
    Bergthorsdottir R, Leonsson-Zachrisson M, Oden A, Johannsson G (2006) Premature mortality in patients with Addison’s disease: a population-based study. J Clin Endocrinol Metab 91:4849–4853PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Roja Soutodeh
    • 1
  • Jürgen Götz
    • 1
  • Ulrich Tebbe
    • 1
  • Alessandro Cuneo
    • 1
  1. 1.Department I, Cardiology, Angiology, Intensive CareKlinikum Lippe-DetmoldDetmoldGermany

Personalised recommendations